1. Tuck KL, Freeman MP, Hayball PJ, Stretch GL, Stupans I (2001). The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. Journal of Nutrition. 131 : 1993–1996.
2. Caruso D, Visioli F, Patelli R., Galli C, Galli G (2001). Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism. 50 : 1426–1428.
3. Bonanome A, Pagnan A, Caruso D, Toia A, Xamin A, Fedeli E, Berra B, Zamburlini A, Ursini F, Galli G, (2000). Evidence of postprandial absorption of olive oil phenols in humans. Nutrition, Metabolism and Cardiovascular Diseases. 10 : 111–120.
4. Visioli F, Caruso D, Plasmati E, Patelli R, Mulinacci N, Romani A, Galli G, Galli C (2001). Hydroxytyrosol, as a component of olive mill waste water, is dose-dependently absorbed and increases the antioxidant capacity of rat plasma. Free Radical Research. 34 : 301– 305.
5. Manna C, Galletti P, Maisto G, Cucciolla V, Dangelo S, Zappia V (2000). Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Letters. 470 : 341–344.
6. Edwin N. Frankel (2011). Nutritional and biological properties of extra virgin olive oil. J. Agric. Food Chem.
7. Haiwell B, Gutteridge JMC (1999). Free Radicals in Biology and Medicine. Oxford University Press, Oxford.
8. Visioli F, Bellomo G, Montedoro GF, Gallic (1995a). Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis. 117 : 25–32.
9. Visioli F, Galli C (1998). The effect of minor constituents of olive oil on cardiovascular disease : new findings. Nutr Rev. 56 : 142– 147.
10. Aruoma OI, Deiana M, Jenner A, Halliwell B, Harparkash K, Banni S, Corongiu FF, Dessi MA, Aeschbach R (1998). Effect of hydroxytyrosol found in extravirgin olive oil on DNA damage and on low-density lipoprotein oxidation. Journal of Agricultural and Food Chemistry. 46: 5181–5187.
11. Keceli T, Gordon MH (2001). The antioxidant activity and stability of the phenolic fraction of green olives and extra virgin olive oil. Journal of the Science of Food and Agriculture. 81 : 1391–1396.
12. Mukherjee S, Lekli I, Gurusamy N, Bertelli AAA, Das DK (2009). Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radical Biology & Medicine. 46 : 573–578.
13. Raederstorff D, Wang-schmidt Y, Wertz K (2010). Use of hydroxytyrosol as anti-aging agent. Pub. No. : US 2010/0130621 A1.
14. Lee-Huang S, Zhang L, Huang PL, Chang YT (2003). Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun; 307:1029–1037.
15. Hamdi KH, Castellon R (2005). Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochemical and Biophysical Research Communications. 334: 769 778.
16. Han J, Talorete TP, Yamada P, Isoda H (2009). Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 59:45–53.
17. Huang CL, Sumpio BE (2008). Olive oil, the Mediterranean diet, and cardiovascular health. J Am Coll Surg. 207:407–16.
18. Cominacini L, Garbin U, Cenci B, Davoli A (1991). Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to a-tocopherol content in humans. Clinica Chimica Acta. 204: 57–68.
19. Rice-Evans CA, Miller NJ, Paganga G (1996). StructureAantioxidant activity relationship of flavonoids and phenolic acids. Free Radical Biology and Medicine. 20: 933–956.
20. Cao G, Sofic E, Prior RL (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radical Biology and Medicine. 22: 749–760.
21. Masella R, Cantafora A, Modesti D, Cardilli A, Gennnaro L, Bocca A, Coni E (1999). Antioxidant activity of 3, 4-DHPEA-EA and protocatechuic acid: a comparative assessment with other olive oil biophenols. Redox Report. 4: 113–121.
22. Halliwell B (1997). Antioxidants and human disease : a general introduction. Nutrition Reviews. 55, 44–52.
23. Leenen R, Roodenburg AJ, Vissers MN, Schuurbiers JA, van Putte KP, Wiseman SA , van de Put FH (2002). Supplementation of plasma with olive oil phenols and extracts: influence on LDL oxidation. Journal of Agricultural and Food Chemistry. 50: 1290–1297.
24. Benkhalti F, Prost J, Paz E, Perez-Jimenez F, El Modafar C, El Boustani E (2002). Effects of feeding virgin olive oil or their polyphenols on lipid of rat liver. Nutrition Research. 22: 1067–1075.
25. Dell’Agli M, Maschi O, Galli G (2007). Inhibition of platelet aggregation by olive oil phenols via cAMP phosphodiesterase. Br J Nutr. 11:1–7.
26. Esposito K, Marfella R, Ciotola M, (2004). Effect of a Mediterranean style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 292:1440–1446.
27. Dell’Agli M, Fagnani R, Mitro N (2006). Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation. J Agric Food Chem. 54: 3259–3264.
28. Carluccio M, Siculella L, Ancora M, (2003). Olive oil and re d wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic proper ties of Mediterranean diet phytochemicals. Ar terioscler Thromb Vasc Biol. 23:622–629.
29. Estruch R, Mar tinez-Gonzalez M, Corella D (2006). Effects of a Mediterranean-style diet on cardiovascular risk factors. Ann Int Med. 145:1–11.
30. de Groot E, Hovingh G, Wiegman A, (2004). Measurement of ar terial wall thickness as a surrogate marker for atherosclerosis. Circulation. 109: III33–III38.
31. Buil-Cosiales P, Irimia P, Berrade N, (2008). Carotid intima-media thickness is inversely associated with olive oil consumption. Atherosclerosis. 196:742–748.
32. Psaltopoulou T, Naska A, Ofranos P (2004). Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 80: 1012–1018.
33. Capasso R, Evidente A, Schivo L, Orru G, Marcialis MA, Cristinzio G (1995). Antibacterial polyphenols from olive oil mill waste waters. Journal of Applied Bacteriology. 79: 393–398.
34. Bisignano G, Tomaino A, Lo Cascio R, Crisafi G, Uccella N, Saija A (1999). On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. Journal of Pharmacy and Pharmacology. 51: 971–974.
35. Hamden K, Carreau S, Lajmi S, Aloulou D, kchaou D, Elfeki A (2008). Protective effect of 1,7-estradiol on hyperglycemia, stress oxidant, liver dysfunction and histological changes induced by alloxan in male rat pancreas and liver. Steroids. 94: 495–501.
36. Daccache A, Lion C, Sibille N, Gerard M, Slomianny C, Lippens G, Cotelle P (2011). Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochemistry International.
37. Somova L.I, Shode, F.O, Ramnanan P, Nadar A (2003). Antihypertensive, antiatherosclerotic, and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J. Ethnopharmacol. 84, 299–305.
38. Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C (2008). Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother. Res. 22, 1239–1242.
